Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-12-08

FDA Approved: LORATADINE ODT — Supplemental Application (Aurohealth LLC)

View source ↗

Summary

FDA approved a supplemental application for Loratadine ODT from Aurohealth LLC, updating the labeling for loratadine in an orally disintegrating tablet form.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LORATADINE ODT (Loratadine)

Snippet

SUPPL AP for LORATADINE ODT (LORATADINE)